Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Ruff

Showing results (51-60 of 93) with videos related to

Pageof 10
Sort By:
The Lancet. Oncology|April 18, 2014
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 studyTimothy J Price, Marc Peeters, Tae Won Kim, et al.
The Oncologist|December 7, 2018
Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer TherapyDaniel S O'Neil, Sarah Nietz, Ines Buccimazza, et al.
Journal of Global Oncology|September 23, 2018
Illness Understanding and End-of-Life Care Communication and Preferences for Patients With Advanced Cancer in South AfricaMegan Johnson Shen, Holly G Prigerson, Mpho Ratshikana-Moloko, et al.
Cancer Epidemiology|January 7, 2018
Breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11Herbert Cubasch, Caroline Dickens, Maureen Joffe, et al.
Journal of Pain and Symptom Management|February 2, 2019
A Prospective Cohort Study of Factors Associated With Place of Death Among Patients With Late-Stage Cancer in Southern AfricaCharmaine L Blanchard, Oluwatosin Ayeni, Daniel S O'Neil, et al.
JCO Global Oncology|January 12, 2021
Quality of Histopathological Reporting in Breast Cancer: Results From Four South African Breast UnitsArmand Toma, Daniel O'Neil, Maureen Joffe, et al.
BMC Gastroenterology|July 15, 2020
Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIVTongai Gibson Maponga, Richard H Glashoff, Hannali Vermeulen, et al.
Gynecologic Oncology|August 9, 2020
Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancerAndres Redondo, Nicoletta Colombo, Mary McCormack, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2013
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trialJosep Tabernero, Eric Van Cutsem, Radek Lakomý, et al.
Breast Cancer Research and Treatment|March 3, 2023
Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancerThérèse Dix-Peek, Boitumelo P Phakathi, Eunice J van den Berg, et al.
Pageof 10

Showing results (51-60 of 93) with videos related to

Sort By:
Pageof 10
The Lancet. Oncology|April 18, 2014
Panitumumab versus cetuximab in patients with chemotherapy-refractory wild-type KRAS exon 2 metastatic colorectal cancer (ASPECCT): a randomised, multicentre, open-label, non-inferiority phase 3 studyTimothy J Price, Marc Peeters, Tae Won Kim, et al.
The Oncologist|December 7, 2018
Neoadjuvant Chemotherapy Use for Nonmetastatic Breast Cancer at Five Public South African Hospitals and Impact on Time to Initial Cancer TherapyDaniel S O'Neil, Sarah Nietz, Ines Buccimazza, et al.
Journal of Global Oncology|September 23, 2018
Illness Understanding and End-of-Life Care Communication and Preferences for Patients With Advanced Cancer in South AfricaMegan Johnson Shen, Holly G Prigerson, Mpho Ratshikana-Moloko, et al.
Cancer Epidemiology|January 7, 2018
Breast cancer survival in Soweto, Johannesburg, South Africa: A receptor-defined cohort of women diagnosed from 2009 to 11Herbert Cubasch, Caroline Dickens, Maureen Joffe, et al.
Journal of Pain and Symptom Management|February 2, 2019
A Prospective Cohort Study of Factors Associated With Place of Death Among Patients With Late-Stage Cancer in Southern AfricaCharmaine L Blanchard, Oluwatosin Ayeni, Daniel S O'Neil, et al.
JCO Global Oncology|January 12, 2021
Quality of Histopathological Reporting in Breast Cancer: Results From Four South African Breast UnitsArmand Toma, Daniel O'Neil, Maureen Joffe, et al.
BMC Gastroenterology|July 15, 2020
Hepatitis B virus-associated hepatocellular carcinoma in South Africa in the era of HIVTongai Gibson Maponga, Richard H Glashoff, Hannali Vermeulen, et al.
Gynecologic Oncology|August 9, 2020
Primary results from CECILIA, a global single-arm phase II study evaluating bevacizumab, carboplatin and paclitaxel for advanced cervical cancerAndres Redondo, Nicoletta Colombo, Mary McCormack, et al.
European Journal of Cancer (Oxford, England : 1990)|October 22, 2013
Aflibercept versus placebo in combination with fluorouracil, leucovorin and irinotecan in the treatment of previously treated metastatic colorectal cancer: prespecified subgroup analyses from the VELOUR trialJosep Tabernero, Eric Van Cutsem, Radek Lakomý, et al.
Breast Cancer Research and Treatment|March 3, 2023
Discordance between PAM50 intrinsic subtyping and immunohistochemistry in South African women with breast cancerThérèse Dix-Peek, Boitumelo P Phakathi, Eunice J van den Berg, et al.
Pageof 10